Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Return on Assets: 2009-2025

Historic Return on Assets for Madrigal Pharmaceuticals (MDGL) over the last 11 years, with Sep 2025 value amounting to -0.24%.

  • Madrigal Pharmaceuticals' Return on Assets rose 24.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year increase of 24.00%. This contributed to the annual value of -0.55% for FY2024, which is 19.00% up from last year.
  • According to the latest figures from Q3 2025, Madrigal Pharmaceuticals' Return on Assets is -0.24%, which was up 14.14% from -0.28% recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Return on Assets registered a high of -0.24% during Q3 2025, and its lowest value of -1.46% during Q3 2022.
  • In the last 3 years, Madrigal Pharmaceuticals' Return on Assets had a median value of -0.48% in 2024 and averaged -0.63%.
  • As far as peak fluctuations go, Madrigal Pharmaceuticals' Return on Assets slumped by 71bps in 2022, and later surged by 81bps in 2024.
  • Quarterly analysis of 5 years shows Madrigal Pharmaceuticals' Return on Assets stood at -0.84% in 2021, then declined by 30bps to -1.13% in 2022, then climbed by 28bps to -0.85% in 2023, then surged by 41bps to -0.44% in 2024, then climbed by 24bps to -0.24% in 2025.
  • Its Return on Assets was -0.24% in Q3 2025, compared to -0.28% in Q2 2025 and -0.38% in Q1 2025.